-
公开(公告)号:US12297210B2
公开(公告)日:2025-05-13
申请号:US17156384
申请日:2021-01-22
Applicant: Genentech, Inc.
Inventor: Terry Kellar , Jun Liang , Sushant Malhotra , Rohan V. Mendonca , Michael Siu , Craig Stivala , John C. Tellis , BinQing Wei , Bryan K. Chan , Lewis J. Gazzard , Timothy Heffron , Graham Jones , Michael Lainchbury , Andrew Madin , Eileen Mary Seward , Matthew W. Cartwright , Emanuela Gancia , David Favor , Kin Chiu Fong , Andrew Good , Yonghan Hu
IPC: C07D519/00 , A61P37/04 , C07D471/04
Abstract: Naphthyridine compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
-
公开(公告)号:US11944606B2
公开(公告)日:2024-04-02
申请号:US17178021
申请日:2021-02-17
Applicant: Genentech, Inc.
Inventor: Timothy Heffron , Sushant Malhotra , BinQing Wei , Bryan Chan , Lewis Gazzard , Emanuela Gancia , Michael Lainchbury , Andrew Madin , Eileen Seward , Yonghan Hu
IPC: A61K31/437 , A61K31/444 , A61K31/506 , A61K31/513 , A61K31/5377 , C07D471/04
CPC classification number: A61K31/437 , A61K31/444 , A61K31/506 , A61K31/513 , A61K31/5377 , C07D471/04
Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
-
公开(公告)号:US20220370420A1
公开(公告)日:2022-11-24
申请号:US17204089
申请日:2021-03-17
Applicant: Genentech, Inc.
Inventor: Sushant Malhotra , Craig Stivala , BinQing Wei , Bryan K. Chan , Timothy Heffron , Michael Lainchbury , Andrew Madin , Terry Aaron Panchal , Eileen Mary Seward , Toby Blench , Matthew W. Cartwright , Elsa Amandine Dechaux , Richard Elliott , Emanuela Gancia
IPC: A61K31/437 , A61K45/06 , C07D471/10 , C07D491/20 , C07D519/00 , C07D487/20 , C07D471/20 , A61K31/5377 , A61K31/444 , A61K31/496 , A61K31/513 , A61K31/4985
Abstract: Spirocyclic 2,3-dihydro-7-azaindole compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the spirocyclic 2,3-dihydro-7-azaindole compounds.
-
公开(公告)号:US11034692B1
公开(公告)日:2021-06-15
申请号:US16542129
申请日:2019-08-15
Applicant: Genentech, Inc.
Inventor: Bryan Chan , Blake Daniels , Joy Drobnick , Lewis Gazzard , Timothy Heffron , Malcolm Huestis , Jun Liang , Sushant Malhotra , Rohan Mendonca , Naomi Rajapaksa , Michael Siu , Craig Stivala , John Tellis , Weiru Wang , BinQing Wei , Aihe Zhou , Matthew W. Cartwright , Emanuela Gancia , Graham Jones , Michael Lainchbury , Andrew Madin , Eileen Seward , David Favor , Kin Chiu Fong , Andrew Good , Yonghan Hu , Baihua Hu , Aijun Lu
IPC: C07D471/04 , A61K45/06 , A61P35/00 , A61K31/444 , A61K31/4375 , A61K31/506 , C07D519/00 , A61K31/4545 , A61K31/4725 , A61K31/5383 , A61K31/496 , A61K31/5377 , A61K31/5025 , A61K31/551 , A61K31/55
Abstract: Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
-
公开(公告)号:US10952995B2
公开(公告)日:2021-03-23
申请号:US16568459
申请日:2019-09-12
Applicant: Genentech, Inc.
Inventor: Timothy Heffron , Sushant Malhotra , BinQing Wei , Bryan Chan , Lewis Gazzard , Emanuela Gancia , Michael Lainchbury , Andrew Madin , Eileen Seward , Yonghan Hu
IPC: A61K31/437 , A61K31/444 , A61K31/506 , A61K31/513 , A61K31/5377 , C07D471/04
Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
-
-
-
-